NCT00987077View on ClinicalTrials.gov

Selective Retina Therapy (SRT) in Patients With Idiopathic Central Serous Retinopathy

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Central Serous ChorioretinopathySelective Retina Therapy
Interventions
DEVICE

Selective Retina Therapy (SRT)

SRT (pulsed double-Q-switched Nd-YLF laser, wavelength 527 nm, t=1.7 µs, energy 100-370 μJ).

Trial Locations (1)

24105

Department of Ophthalmology, Kiel

All Listed Sponsors
collaborator

Medical Laser Center Lübeck, Lübeck, Germany

UNKNOWN

collaborator

Institute for Medical Informaties and Statistics Kiel, Germany

UNKNOWN

lead

University of Kiel

OTHER

NCT00987077 - Selective Retina Therapy (SRT) in Patients With Idiopathic Central Serous Retinopathy | Biotech Hunter | Biotech Hunter